scholarly article | Q13442814 |
P2093 | author name string | Jochen Senges | |
Bernhard Rauch | |||
P2860 | cites work | Fish consumption and the 30-year risk of fatal myocardial infarction | Q73199941 |
Fish consumption and risk of sudden cardiac death | Q74019958 | ||
Highly purified omega-3 fatty acids for secondary prevention of sudden cardiac death after myocardial infarction-aims and methods of the OMEGA-study | Q79379929 | ||
JELIS, fish oil, and cardiac events | Q80071276 | ||
Fish oils in the care of coronary heart disease patients: a meta-analysis of randomized controlled trials | Q80857022 | ||
Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials | Q81235960 | ||
Dietary (n-3) long-chain polyunsaturated fatty acids inhibit ischemia and reperfusion arrhythmias and infarction in rat heart not enhanced by ischemic preconditioning | Q82018125 | ||
n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study | Q82362778 | ||
Is fish oil good or bad for heart disease? Two trials with apparently conflicting results | Q82461785 | ||
Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human pulmonary vein and left atrial electrophysiology in paroxysmal atrial fibrillation | Q84224249 | ||
Changes in phospholipid fatty acid composition of mouse cardiac organelles after feeding graded amounts of docosahexaenoate in presence of high levels of linoleate. Effect on cardiac ATPase activities | Q93523391 | ||
Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia. Possible implications for the protective mechanism of ischemic preconditioning | Q93865618 | ||
Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review | Q24541608 | ||
External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids | Q24564480 | ||
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
Do statins influence the prognostic impact of non-sustained ventricular tachycardia after ST-elevation myocardial infarction? | Q28218058 | ||
Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study | Q29620117 | ||
A comprehensive review and analysis of 25 years of data from an in vivo canine model of sudden cardiac death: implications for future anti-arrhythmic drug development | Q31032514 | ||
Effect of fish oil on arrhythmias and mortality: systematic review | Q33395578 | ||
Omega-3 fatty acids in high-risk cardiovascular patients: a meta-analysis of randomized controlled trials | Q33594958 | ||
Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes | Q33749115 | ||
Docosahexaenoic acid has influence on action potentials and transient outward potassium currents of ventricular myocytes | Q33820244 | ||
Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes | Q33834437 | ||
Fish intake and risk of incident atrial fibrillation | Q33947310 | ||
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. | Q33958979 | ||
Membrane effects of the n-3 fish oil fatty acids, which prevent fatal ventricular arrhythmias | Q33993322 | ||
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review | Q33997472 | ||
Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. | Q34018540 | ||
Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease | Q34059526 | ||
Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils | Q34202333 | ||
Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events | Q34229907 | ||
Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia | Q34339864 | ||
Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial | Q34356824 | ||
Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial | Q34426589 | ||
Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). | Q34464251 | ||
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake | Q34464868 | ||
Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions | Q34514084 | ||
N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials | Q34521626 | ||
Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models | Q34524193 | ||
Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial | Q34537916 | ||
Pro- and antiarrhythmic properties of a diet rich in fish oil. | Q34549996 | ||
Antiarrhythmic effects of omega-3 fatty acids | Q34558776 | ||
Fish intake, contaminants, and human health: evaluating the risks and the benefits | Q34574664 | ||
Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis | Q34578231 | ||
Incorporated fish oil fatty acids prevent action potential shortening induced by circulating fish oil fatty acids | Q34691809 | ||
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design | Q35100790 | ||
Mechanical effects on arrhythmogenesis: from pipette to patient. | Q35121854 | ||
Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations--a comparative bioavailability study of fish oil vs. krill oil. | Q35200566 | ||
n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes | Q35563657 | ||
Beta blockers as anti-arrhythmic agents | Q35934111 | ||
Fatty acids suppress voltage-gated Na+ currents in HEK293t cells transfected with the alpha-subunit of the human cardiac Na+ channel | Q35935540 | ||
Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes | Q36111398 | ||
Dietary long-chain omega-3 fatty acids of marine origin: a comparison of their protective effects on coronary heart disease and breast cancers. | Q36187421 | ||
A systematic review and meta-analysis of the impact of omega-3 fatty acids on selected arrhythmia outcomes in animal models | Q36323919 | ||
Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis | Q36327925 | ||
Evidences of the gender-related differences in cardiac repolarization and the underlying mechanisms in different animal species and human | Q36382611 | ||
Membrane basis for fish oil effects on the heart: linking natural hibernators to prevention of human sudden cardiac death. | Q36386145 | ||
Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids | Q36858387 | ||
Anti-arrhythmic properties of N-3 poly-unsaturated fatty acids (n-3 PUFA). | Q36907305 | ||
Modulation of enzymatic activities by n-3 polyunsaturated fatty acids to support cardiovascular health | Q36955145 | ||
Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review | Q37234350 | ||
Heterogeneity in randomized controlled trials of long chain (fish) omega-3 fatty acids in restenosis, secondary prevention and ventricular arrhythmias | Q37288199 | ||
Omega-3 fatty acid: a role in the management of cardiac arrhythmias? | Q37301257 | ||
Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials | Q37370040 | ||
Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training | Q37580600 | ||
Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins | Q37661135 | ||
Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial | Q37665100 | ||
Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials | Q37863370 | ||
n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study | Q38486278 | ||
Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial | Q38497733 | ||
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction | Q38497919 | ||
Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction | Q38701805 | ||
Meta-analysis of observational studies on fish intake and coronary heart disease | Q39589106 | ||
Amphipathic metabolites and membrane dysfunction in ischemic myocardium | Q40076674 | ||
The influence of dietary lipid supplementation on cardiac beta-adrenergic receptor adenylate cyclase activity in the marmoset monkey. | Q42501329 | ||
Effect of dietary fish oil on atrial fibrillation after cardiac surgery | Q42609311 | ||
Effects of n-3 polyunsaturated fatty acids on malignant ventricular arrhythmias in patients with chronic heart failure and implantable cardioverter-defibrillators: A substudy of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienz | Q42690218 | ||
Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats | Q42781416 | ||
n-3 fatty acids and cardiovascular events after myocardial infarction | Q42867424 | ||
Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both | Q42957325 | ||
A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk | Q43100753 | ||
Blood levels of long-chain n-3 fatty acids and the risk of sudden death | Q43955896 | ||
Lack of benefit of dietary advice to men with angina: results of a controlled trial | Q44305198 | ||
N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. | Q44754719 | ||
Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study | Q44949398 | ||
Membrane fluidity changes are associated with the antiarrhythmic effects of docosahexaenoic acid in adult rat cardiomyocytes | Q45147815 | ||
Fish and omega-3 fatty acid intake and risk of coronary heart disease in women | Q45305759 | ||
Rat vs. rabbit ventricle: Ca flux and intracellular Na assessed by ion-selective microelectrodes. | Q45990555 | ||
The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy | Q46265973 | ||
Antiarrhythmic and electrophysiological effects of long-chain omega-3 polyunsaturated fatty acids | Q46496293 | ||
Species difference in the contribution of T-type calcium current to cardiac pacemaking as revealed by r(-)-efonidipine | Q46609183 | ||
Acute administration of fish oil inhibits triggered activity in isolated myocytes from rabbits and patients with heart failure. | Q46808218 | ||
Fish oil curtails the human action potential dome in a heterogeneous manner: implication for arrhythmogenesis | Q46882895 | ||
Enhanced increase of omega-3 index in response to long-term n-3 fatty acid supplementation from triacylglycerides versus ethyl esters | Q50555472 | ||
Mediterranean dietary pattern in a randomized trial: prolonged survival and possible reduced cancer rate. | Q50882625 | ||
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. | Q51891974 | ||
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both | Q57396339 | ||
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial | Q57628867 | ||
Dietary n-3 fatty acids promote arrhythmias during acute regional myocardial ischemia in isolated pig hearts☆ | Q63871544 | ||
Dietary fish oil reduces the occurrence of early afterdepolarizations in pig ventricular myocytes | Q63871545 | ||
Incorporated sarcolemmal fish oil fatty acids shorten pig ventricular action potentials | Q63871546 | ||
Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor | Q69725656 | ||
Phospholipid alterations in canine ischemic myocardium. Temporal and topographical correlations with Tc-99m-PPi accumulation and an in vitro sarcolemmal Ca2+ permeability defect | Q70723072 | ||
Membrane docosahexaenoic acid vs. eicosapentaenoic acid and the beating function of the cardiomyocyte and its regulation through the adrenergic receptors | Q71319618 | ||
Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest | Q71752852 | ||
Antiarrhythmic effects of eicosapentaenoic acid during myocardial infarction--enhanced cardiac microsomal (Ca(2+)-Mg2+)-ATPase activity | Q72117483 | ||
Effects of excess free fatty acids on the electrophysiological properties of ventricular specialized conducting tissue: a comparative study between the sheep and the dog | Q72668514 | ||
Effect of phospholipid hydrolysis by phospholipase A2 on the kinetics of antagonist binding to cardiac muscarinic receptors | Q72767400 | ||
Effects of dietary n-3 fatty acids on contractility, Na+ and K+ currents in a rat cardiomyocyte model of arrhythmia | Q73109278 | ||
Inhibition of cardiac sodium currents in adult rat myocytes by n-3 polyunsaturated fatty acids | Q73141588 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
P304 | page(s) | 57 | |
P577 | publication date | 2012-04-02 | |
P1433 | published in | Frontiers in Physiology | Q2434141 |
P1476 | title | The effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends… | |
P478 | volume | 3 |